Naltrexone vs Buprenorphine as First Line Therapy
Presenter(s):

This will be a one hour discussion led by John Lopes, PA-C. The topic subject is “Naltrexone vs Buprenorphine as First Line Therapy .” This discussion is designed to promote interactivity through an informal “round table” conversation. Please provide a case/question that you would like to see discussed. This will help the format the discussion.

Note: This Clinical Roundtable is not designated for AMA PRA Category 1 Credit™.

Organizer(s):